SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

5 Jun 2026 13:39

RNS Number : 2253H
Caledonia Investments PLC
05 June 2026
 

 

Caledonia Investments plc

 

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

 

Caledonia Investments plc ("Caledonia" or the "Company") has been notified pursuant to the requirements of the UK Market Abuse Regulation ("MAR") of the following transactions in its ordinary shares of 0.5p ("Shares") involving one of its directors, Mathew Masters.

 

On 4 June 2026, 94,938 Shares were transferred to Mr Masters under the Caledonia Investments 2020 Performance Share Scheme at nil cost. The Shares were sourced from The Caledonia 2024 Employee Benefit Trust ("EBT"). 

 

On the same date, Mr Masters sold 44,761 Shares back to the EBT to meet the tax liability due. All Shares were sold at 360.25p per Share. He retained 50,177 Shares.

 

Following the above transactions, Mr Masters' total interests in Shares are as follows: 

 

Description

Number of Shares

Percentage of voting rights

Beneficial

793,957

0.1543%

Non-beneficial

nil

n/a

Performance share scheme awards

912,584

0.1773%

Deferred bonus plan awards

56,740

0.0110%

Shares held under the Caledonia Investments Share Incentive Plan

1,176

0.0002%

 

Further information required by MAR in relation to these transactions is set out in the appendix below.

 

Enquiries:

Alex Pollard

Senior Assistant Company Secretary

Tel: + 44 20 7802 8080

 

5 June 2026

APPENDIX

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Mathew Simon Dexter Masters

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director/Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 0.5p shares

 

 

 

GB00BTNQ8K38

b)

 

Nature of the transaction

 

 

Exercise of Caledonia Investments 2020 Performance Share Scheme ("2020 PSS") awards

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£0.00

94,938

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A (single transaction)

e)

 

Date of the transaction

 

4 June 2026

f)

Place of the transaction

London - outside a trading venue

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 0.5p shares

 

 

 

GB00BTNQ8K38

b)

 

Nature of the transaction

 

 

Partial sale of shares to meet tax liability arising from 2020 PSS exercise

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£3.6025

44,761

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A (single transaction)

e)

 

Date of the transaction

 

4 June 2026

f)

Place of the transaction

XLON

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBDGDLIXGDGLU
Date   Source Headline
11th Jun 20263:30 pmRNSAnnual report 2026 and notice of AGM
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20261:39 pmRNSDirector/PDMR Shareholding
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20269:00 amRNSNet Asset Value(s)
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20265:08 pmRNSDirector/PDMR Shareholding
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 202611:02 amRNSCompletion of Stonehage Fleming sale
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20269:42 amRNSDirector/PDMR Shareholding
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 20262:34 pmRNSDirector Declaration
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSBoard changes
19th May 20267:00 amRNSFinal Results
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSNotice of Results
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20265:32 pmRNSHolding(s) in Company
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 202611:00 amRNSNet Asset Value(s)
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20264:39 pmRNSDirector Declaration
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20264:47 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20263:51 pmRNS-RQuotedData's In The HotSeat Special
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.